GlassScriptPhysician profile
Ronald J Moore
NPI 1316902679
$20,952.98
in general payments reported to CMS, 2019-2025
12 companies · $749 in 2025
The $749 reported for 2025 was more than what 86% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,764 · 2022: $3,676 · 2023: $8,456 · 2024: $6,308 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,544 · Consulting Fee: $5,000 · Food and Beverage: $3,840 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,543.52 |
| Consulting Fee | $5,000.00 |
| Food and Beverage | $3,839.64 |
| Education | $130.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $9,678.83 | 2022-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $8,874.36 | 2021-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Artivion, INC. | $720.04 | 2021-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Photofix Decellularized Bovine Pericardium |
| Medtronic, INC. | $647.54 | 2023 | Corevalve Evolut R |
| Boston Scientific Corporation | $404.96 | 2021-2022 | |
| Abbott Laboratories | $345.20 | 2021-2022 | |
| Baxter Healthcare | $97.48 | 2021-2023 | Floseal |
| Terumo Cardiovascular Systems Corporation | $91.50 | 2021-2023 | Virtuosaph Plus With Radial Indication, Herc Flex Universal Stabilizer Arm |
| Inari Medical, INC. | $30.43 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Chiesi USA, INC. | $24.73 | 2025 | Kengreal, Cleviprex |
| Pacira Pharmaceuticals Incorporated | $19.61 | 2025 | Exparel |
| Penumbra, INC. | $18.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.